Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, supplying promising breakthroughs throughout different clinical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, m